Company intelligence / Profile preview

Basil Systems

Boston, Massachusetts, USA

Ownership: Private
Development stage: Other

Overview

Basil Systems provides an AI-powered platform that enables pharmaceutical and MedTech companies to make smarter real-time decisions regarding regulatory, clinical, product lifecycle, and market strategies using its proprietary, indexed data covering hundreds of millions of records from global regulatory filings, clinical trials, drug/device labels, adverse event reports, and recalls.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Johnson & Johnson (client, regulatory affairs use case)Medtronic (client)Baxter (client)Boston Scientific (client)In active trials with three of top global pharmaceutical companies (names not disclosed)

Beyond the preview

Go deeper on Basil Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Basil Systems.

Explore the full profile